Cleared Traditional

K895277 - ORTHO APO B ELISA TEST SYSTEM

K895277 is an FDA 510(k) clearance for ORTHO APO B ELISA TEST SYSTEM, manufactured by Medical Marketing Consultants, Inc.. The device is a Class 1 Immunology device with product code MSJ cleared through the Traditional 510(k) pathway after a 35-day FDA review.

K895277 · Medical Marketing Consultants, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1989
Decision
35d
Days
Class 1
Risk

K895277 is an FDA 510(k) clearance for the ORTHO APO B ELISA TEST SYSTEM. Classified as Apolipoproteins (product code MSJ), Class I - General Controls.

Submitted by Medical Marketing Consultants, Inc. (Bethesda, US). The FDA issued a Cleared decision on September 27, 1989 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1475 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medical Marketing Consultants, Inc. devices

FDA 510(k) Submission Details - K895277

510(k) Number K895277 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 23, 1989
Decision Date September 27, 1989
Days to Decision 35 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 105d · This submission: 35d
Pathway characteristics
Predicate-based equivalence.

MSJ Device Classification - Class 1, General Controls

Product Code MSJ Apolipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MSJ Apolipoproteins

All 38
Devices cleared under the same product code (MSJ) and FDA review panel - the closest regulatory comparables to K895277.
REFLAB(TM) BR SYST PACK LIQ REAG, APOLIPOPROTEIN B
K912749 · Medical Analysis Systems, Inc. · Sep 1991
ROCHE REAGENT FOR APOLIPOPROTEIN A-1
K910551 · Roche Diagnostic Systems, Inc. · May 1991
ROCHE REAGENT FOR APOLIPOPROTEIN B
K910552 · Roche Diagnostic Systems, Inc. · May 1991
BACTON TM, BASIC TM, APO B REAGENT
K893884 · Catachem, Inc. · Jun 1989
SPQ(TM) ANTIBODY REAGENT SET II FOR APO A-I/APO B
K891154 · Atlantic Antibodies · Mar 1989
QM300 APOLIPOPROTEIN A-I ANTIBODY PACK
K883713 · Kallestad Diag, A Div. of Erbamont, Inc. · Oct 1988